New WHO Guidelines on Primary Prevention of Cardiovascular disease
S. Mendis (Switzerland)

WHO Risk Prediction Charts for Cardiovascular Disease
S. Lim (Australia)

The challenges for CVD prevention in Europe
L. Ryden (Sweden)

The UK experience
K.Bennet (Ireland)

The Nordic countries experience (Finland and Sweden)
A.Rosengren (Sweden)

The Chinese experience
J. Critchley (UK)

The Italian experience
L.Palmieri (Italy)

Conclusions to date and future possibilities
S.Capewell (UK)

Prevention & Rehabilitation:
Barriers to the delivery of cardiac rehabilitation and prevention programmes: why do not cardiologist / cardiac surgeon ensure their patients take part in CR?
Organized by Miguel Mendes
Chairs: P. Ponikowski (Poland), M.Piepoli (Italy)

What are the cardiac rehabilitation benefits in terms of outcomes and costing
N. Oldridge (US)

Uptake of CR in the UK and strategies adopted by the UK campaign for cardiac rehabilitation
R. Lewin (UK)

Uptake of CR in Belgium and strategies adopted to improve the situation
P. Dendale (Belgium)

The opinion of :

• the cardiac surgeon
  B. Keogh (UK)
• the interventional cardiologist
  A. Colombo (Italy)

Debate

Prevention & Rehabilitation
Non-invasive measures of vessel damage: useful screening tools for CVD?
Organized by Harry Hemingway
Chairs: P. Whincup (UK), J. Witteman (The Netherlands)

The ankle-arm index: ready to be included in risk stratification?
F. G. Fowkes (UK)

Defining the role of coronary artery calcification measurements - a clinical perspective
A. Schmermund (Germany)

Non-invasive assessment of endothelial function. A valuable prognostic tool in risk assessment?
J. Halcox (TBC)

Comparative performance of sub-clinical atherosclerosis markers in predicting coronary heart disease
A. Simon (France)

Exercise & Sports Cardiology
New insights into the prognostic value of cardiopulmonary exercise testing in chronic heart failure
Organized by Luc Vanhees
Chairs: P Dubach (Switzlerland), L Vanhees (Belgium)

Evaluation of prognosis in chronic heart failure
P. Dubach (Switzerland)

Traditional exercise parameters (VO2max, AT, Workload)
A. Cohen-Solal (France)

New exercise parameters
P. Giannuzzi (Italy)

Comprehensive evaluation of prognosis using cardiopulmonary exercise test
U. Corrá (Italy)

1- Epidemiology & Public Health
2- Prevention & Rehabilitation
3- Prevention & Rehabilitation
4- Exercise & Sports Cardiology

Spain: the loss of the Mediterranean protection?
S. Sans (Spain)

Cardiovascular risk factors in central and eastern Europe: the HAPIEE study
M. Bobak (UK)

Cardiovascular disease in a Russian population: recent trends in risk factors and cohort findings
S. Malyutina (Russia)

Alcohol and ethanol-based substitutes and mortality in a Russian city
D. Leon (UK)

Prevention & Rehabilitation
Social patterning of cardiovascular diseases
Organized by Harry Hemingway
Chairs: D. Batty (UK), K. Orth-Gomer (Sweden)

Women and psychosocial factors
A.Rosengren (Sweden)

Social differences in CVD: Do we understand the biology? Do we need to?
E. Brunner (UK)

Psychosocial factors at work and CVD?
M. Kivimaki (Finland)

Cardiovascular disease: a sociological perspective
J. Siegrist (Germany)

Prevention & Rehabilitation
Quality assurance in cardiovascular prevention and rehabilitation
Joint Session between AACVPR and EACPR
Organized by David Wood
Chairs: J. Hereford (USA), D. Wood (UK)

Performance measures in cardiac rehabilitation
M. King (USA)

The UK National Audit of Cardiac Rehabilitation, principles, method and some early results
B. Lewin (UK)

The National Audit of Cardiac Rehabilitation in Ireland, methods and some early results.
F. Doyle (Ireland)

Audit and electronic entry systems?
W. Benzer (Austria)

How to get everyone to cooperate: experience from the CARINEX Study
H. McGee (Ireland)

Program certification in the US
J. Hereford (USA)

Exercise & Sports Cardiology
Importance of exercise intensity in cardiovascular disease – evidence from bench and bedside
Organized by Luc Vanhees
Chairs: L. Vanhees (Belgium), S. Gielen (Germany)

How should we measure exercise intensity?
A. Cohen-Solal (France)

Aerobic capacity and risk factors for atherosclerotic disease: The fitter, the better?
J. Myers (USA)

Cellular effects of high intensity exercise – from bench to bedside
U. Wisløff (Norway)

Which exercise is more effective in improving exercise capacity? Results from randomized clinical trials
V. Adams (Germany)

Targeting populations or individuals: public health effects of primary prevention
M. Verschuren ( )

How to calculate absolute CVD risk
T. Thomsen (Denmark)

How to measure pre-clinical disease
J. Deanfield (UK)

Exercise an anti-aging intervention: the role of endothelial function
D. Seals (USA)

A joint ESC/EASD initiative on diabetes mellitus
L. Ryden (Sweden)

Lifestyle changes successfully prevent diabetes mellitus type 2
M. Peltonen (Finland)

Endurance training and its effects on skeletal musculature and glucose metabolism
J. Niebauer (Austria)

Strength training in diabetes and insulin resistance
L. van loon (Netherlands)

Future challenges for diabetes mellitus
E. Standl (Germany)

The Global Strategy for the Prevention of Rheumatic Fever: Successes and Failures
E.L. Kaplan (USA)

The A.S.A.P. Programme for the Eradication of Rheumatic Fever in Africa: Can it be Achieved in Our Lifetime?
B. M. Mayosi (South Africa)

Chagas Disease - Prospects for Treatment and Control
C. Morillo (Canada)

Cardiovascular disease surveillance in developing countries -  lessons from the WHO STEPS Programme
A. Damasceno (Mozambique)

Prevention & Rehabilitation
Prognosis and management of hypertension
Joint Session with Working Group on Hypertension and ESH
Organized by David Wood
Chairs: S. Kjeldsen (Norway), R. Fagard (Belgium)

Prognostic significance of the blood pressure and sympathetic response to physical and mental stress testing
G. Grassi (Italy)

Prognostic significance of white-coat, masked and sustained hypertension versus true normotension
R. Fagard (Belgium)

Current insights in the treatment of hypertension
S. Kjeldsen (Norway)

Prevention & Rehabilitation
Lactic and threshold in cardiac rehabilitation
Organized by Miguel Mendes
Chair: L. Vanhees (Belgium), A. Cohen-Solal (France)

Determination of anaerobic threshold: Direct measurement of lactic acid vs. ventilatory anaerobic threshold
U. Corra (Italy)

Lactic acid threshold and other submaximal indices: pathophysiological implication
D. Francis (UK)

Relation between lactate threshold, catecholamines and arrhytmias in cardiac patients
U. Tegtbur (Germany)

Is the knowledge of lactate threshold useful in the assessment of non cardiac patients?
M. Guazzi (Italy)

Is the knowledge of lactate threshold useful in training heart failure patients?
H.-C. Heitkamp (Germany)

Exercise & Sports Cardiology
Challenging clinical cases in Sports Cardiology
Organized by Antonio Pelliccia
Chairs: M. Borjesson (Sweden), N. Panhuyzen (The Netherlands)

Clinical case 1
S. Sharma

Clinical case 2
E. Meijboom

Clinical case 3
A. Boraita

Clinical case 4
D. Treush

Clinical case 5
F. Carre

1- Epidemiology & Public Health
2- Prevention & Rehabilitation I
3- Prevention & Rehabilitation II
4- Exercise & Sports Cardiology

Using genetic variants to make causal inferences about modifiable non-genetic risk factors: brief overview of the potentials and pitfalls of Mendelian Randomization Studies
D. Lawlor (UK)

An example of the use of Mendelian Randomization in cardiovascular disease epidemiology
A. Tybjærg-Hansen (Denmark)

General discussion with all participants

Prevention & Rehabilitation
Cardiovascular Risk Prediction I
Organized by David Wood
Chairs: I. Graham (Ireland), T. Thomsen (Denmark)

Cardiovascular risk prediction in Spain
S. Sans (Spain)

Predicting fatal or non-fatal end-points in cardiovascular risk prediction.
T. Aspelund (Iceland)

Predicting total CVD events; the SCORE perspective
C. McGorrian (Ireland)

Prevention & Rehabilitation
Long term outcomes of Cardiac Rehabilitation
Organized by Miguel Mendes
Chairs: B. Bjarnason-Wehrens (Germany), M. Mendes (Portugal)

Can short term outcomes influence long term survival after cardiac rehabilitation.
W. Benzer (Austria)

How cardiovascular risk factors influence life expectancy and the influence of Cardiac Rehabilitation
R. Griffo (Italy)

Are the long term effects of cardiac rehabilitation the same in CABG or PCI?
D. Hansen (Belgium)

Exercise & Sports Cardiology
Impact of Exercise Training on Progenitor cells
Organized by Rainer Hambrecht
Chairs: R. Hambrecht (Germany), V. Conraads (Belgium)

Is there an impact of exercise training on circulating progenitor cells?
V. Adams (Germany)

Molecular mechanisms triggering the training induced release of progenitor cells
S. Erbs (Germany)

Do oxygen radicals influence the impact of exercise training mediated release of endothelial progenitor cells?
G. Kojda (Germany)

Marathon running and progenitor cells
S. Möhlenkamp (Germany)

Introduction
X. Jouven (France)

When is support needed – the typical patient
M. Ridderstråle (Sweden)

The endocannabinoid system – a review from mouse to man
L. Sjöström (Sweden)

Design and outcome of clinical trials on
overweight, diabetes and dyslipidemia – the RIO programme and beyond
S. Tonstad (Norway)

Illness and health –future perspectives
L. Rydén (Sweden)

Prevention & Rehabilitation
Cardiovascular Risk Prediction II
Organized by David Wood
Chairs: TBC

New risk factors for prediction of CVD
I. Graham (Ireland)

Is heart rate an independent risk factor for CVD?
(TBC)

What are the potential benefits of reducing heart rate for CVD?
(TBC)

Perception of cardiovascular risk factors by the general population
Z. Reiner (Croatia)

Germanic state of the art: The situation in Northern and Central Europe: Scandinavia, Germany, Austria and Switzerland
(TBC)
Intermmediate state of the art: The situation in Western Europe: United Kingdom, France, the Netherlands and Belgium
D.M Mercadet (France)

Latin state of the art: The situation in Mediterannean and Southern Countries: Italy, Portugal and Spain
A. R. Leal (Portugal)

How we manage and have been improving the difficult situation in Spain
V. Sosa (Spain)

Exercise & Sports Cardiology
Preparticipation screening of athletes for cardiovascular disease: a challenging project
Organized by Antonio Pelliccia
Chairs: D. Corrado (Italy), E. Meijboom (Switzerland)

The position of the EACPR
A. Pelliccia (Italy)

The position of the IOC
E. Meijboom (Switzerland)

The position of the FIMS
J. Cummiskey (Ireland)

The position of the FIFA
J. Dvorak (Switzerland)

The position of the UCI
M. Zorzoli (Switzerland)

How to determine exercise training intensity in heart failure patients with or without a device
J.P. Schmid (Switzerland)

How to set up and run a cardiac rehabilitation and prevention programme
H. Saner (Switzerland)

How to evaluate quality of life
N. Oldridge (USA), H. McGee (Ireland)

Screening for preventing sudden cardiac death during exercise and sports
D. Corrado (Italy)
 

The epidemic of CHF and the demographic change in Western societies
A. J. Coats (Australia)

Cardiovascular ageing – An inevitable path to heart failure?
W. Paulus (The Netherlands)

Cardiovascular limitations of exercise tolerance in CHF – Is it possible to distinguish disease from age-associated changes?
J. Senden (The Netherlands)

Prognostic impact of weight loss in old age and heart failure – Is there a difference?
S.Anker (UK)

Muscle wasting and catabolic metabolism in chronic heart failure – Is exercise the key to prevention and treatment?
S. Gielen (Germany)

How to make routine data comparable across Europe
S. Giampaoli (Italy)

Population-based AMI registers
M. Madsen (Denmark)

CVD Surveys
P. Primatesta (UK)

Population-based stroke registers
N. Hammar (Sweden)

Prevention & Rehabilitation
Better prediction of coronary risk using biomarkers, genotypes or both?
Organized by Harry Hemingway
Chairs: J.C. Kaski (UK), I. Graham (Ireland)

Biomarkers and risk prediction in primary prevention
W. Koenig (Germany)

Biomarkers and risk prediction in secondary prevention
S. Blankenberg (Germany)

Determinants and associations of markers of inflammation. Implications for their use for coronary risk prediction
J. Danesh (UK)

Challenges in incorporating genetic information into established risk tools
A. Hingorani (UK)

Prevention & Rehabilitation
Primary prevention for CVD: physical activity
Organized by Simona Giampaoli and Luc Vanhees
Chairs: S. Giampaoli (Italy), L. Vanhees (Belgium)

Lack of regular physical activity as an important risk factor of cardiovascular diseases (according to EBM)
L. Vanhees (Belgium)

Optimal methods of assessing physical activity - what should we choose
U. Ekelund (UK)

Prescriptions to promote physical activity for individuals
D. Dugmore (UK)

Health promoting policies for populations
E. Shelley (Ireland)

Training health professionals
S. Giampaoli (Italy)

Exercise & Sport Cardiology
How to manage athletes with complex arrhythmias or related symptoms?
Organized by Antonio Pelliccia
Chairs: H. Heidbüchel (Belgium), J. Villacastin (Spain)

How to manage athletes with atrial fibrillation?
J. Hoogsteen (The Netherlands)

How to manage athletes with preexcitation?
P. Delise (Italy)

How to manage athletes with nonsustained VT?
A. Biffi (Italy)

How to mange athletes with ICDs and pace-makers?
N. Heidbüchel (Belgium)

How to manage athletes with syncope during or after exercise?
N. Panhuyzen-Goedkoop (The Netherlands)

1- Epidemiology & Public Health
2- Prevention & Rehabilitation I
3- Prevention & Rehabilitation II
4- Exercise & Sports Cardiology

Posters Exhibition

The idea: From brainstorming to clever study design.
A. Linke (Germany)

The planning: From belief to numbers
H. Kuper (UK)

The ethical issue: From pure science to patients’ and animals’ rights
A. Dawson (UK)

Study registration: From clinical science to bureaucracy.
I. Graham (Ireland)

The publication: How to write a scientific manuscript
S. Gielen (Germany)

Prevention & Rehabilitation
Future directions in large, longitudinal clinical dataset research
Organized by Harry Hemingway
Chairs: P.U. Heuschmann (Germany), L. Wallentin (Sweden)

Acute coronary syndrome registers: a perspective from environmental epidemiology
P. Wilkinson (UK)

Are population-based registers the gold standard to mix health services research and causal epidemiological research? The experience of the European Registers of Stroke Collaboration
C. Wolfe (UK)

Can the incidence of myocardial infarction and other vascular diseases be derived from routine hospital statistics on a national level?
M.L. Bots (Netherlands)

Challenges in using primary care data to estimate the burden of vascular diseases in the population: The Database of the Italian College of General Practitioners
A. Filippi (Italy)

Prevention & Rehabilitation
Models of Care in Cardiovascular Prevention and Rehabilitation
Organized by David Wood
Chairs: G. De Backer (Belgium), J. Perk (Sweden)

The role of specialist cardiac rehabilitation programmes
H. Saner (Switzerland)

The role of a nurse led multidisciplinary preventive cardiology programme
C.Jennings (UK)

Home based cardiac rehabilitation
B. Lewin (UK)

Panel discussion (to be chaired by G.De Backer)

Hannah McGee (Ireland)
Miguel Mendes (Portugal)
Tone Norekvål (Norway)
David Thompson (Hong Kong)
Joep Perk (Sweden)
Luc Vanhees (Belgium)

Exercise & Sports Cardiology
How to measure exercise capacity in clinical trials
Joint Session - Section of Basic Science and Section of Exercise Physiology
Organized by Luc Vanhees
Chairs: M. Mendes (Portugal), S. Adamopoulos (Greece)

Treadmill versus bicycle ergometry – What are the differences?
B. Bjarnason-Wehrens (Germany)

Ergospirometry – Maximal oxygen uptake or oxygen uptake efficiency slope?
L. Vanhees (Belgium)

Strength tests – Potentials and precautions in cardiac patients
V. Conraads (Belgium)

The 6-minute walk test – an adequate substitute for ergo(spiro)metry?
J.-P. Schmid (Switzerland)

Physical activity questionnaires – application in epidemiologic trials.
U. Ekelund (UK)

• Journal Prize
• GR Prize
• Poster Prize